SCHEMBL30681455

SCHEMBL30681455

O=C(O)C1CC1c1ccccc1Br

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.52
▸ FFAR1 O14842 2/20 0.47
▸ HTR2C P28335 4/20 0.47
▸ HTR2B P41595 4/20 0.47
▸ SLC6A2 P23975 2/20 0.46
▸ HTR2A P28223 2/20 0.46
▸ SLC6A4 P31645 2/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ HDAC4 P56524 2/20 0.43
▸ BACE1 P56817 4/20 0.43
▸ NR4A2 P43354 2/20 0.41
▸ RXRA P19793 1/20 0.41
▸ RXRB P28702 1/20 0.41
▸ RXRG P48443 1/20 0.41
▸ FABP5 Q01469 1/20 0.41
▸ SLC9A1 P19634 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3476313 1.00 KDM1A (0.52) KDM1AFFAR1HTR2CHTR2BSLC6A2
SCHEMBL4126357 1.00 KDM1A (0.52) KDM1AFFAR1HTR2CHTR2BSLC6A2
SCHEMBL13742600 1.00 KDM1A (0.52) KDM1AFFAR1HTR2CHTR2BSLC6A2
SCHEMBL4987635 0.86 KDM1A (0.42) KDM1AFFAR1HTR2CHTR2BSLC6A2
SCHEMBL4138468 0.84 KDM1A (0.55) KDM1AHTR2CHTR2BSLC6A2HTR2A
SCHEMBL4138471 0.84 KDM1A (0.55) KDM1AHTR2CHTR2BSLC6A2HTR2A
SCHEMBL4986591 0.81 KDM1A (0.41) KDM1AFFAR1HTR2CHTR2BSLC6A2
SCHEMBL4982381 0.81 POLB (0.45) KDM1AHTR2CHTR2BSLC6A2HTR2A
SCHEMBL1817989 0.80 BACE1 (0.61) KDM1AHTR2CHTR2BSLC6A2HTR2A
SCHEMBL1817991 0.80 BACE1 (0.61) KDM1AHTR2CHTR2BSLC6A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540240-A1 MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME Monte Rosa Therapeutics AG (CH) 2025-04-23 — — EP disclosed
WO-2023244815-A1 MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME MONTE ROSA THERAPEUTICS, INC. (US) 2023-12-21 — — WO disclosed
Send feedback